The US Food and Drug Administration (FDA) is adding the risk of anaphylaxis to a new boxed warning of glatiramer acetate, a medicine for multiple sclerosis (MS). The agency issued the warning about ...

A cross-sectional comparative evaluation of the boxed warning in the manufacturer's PI and the boxed warning content in six online drug information resources was conducted. The selected resources ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

Ciprofloxacin has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the “Ciprofloxacin’s side effects explained” section.

Pomalyst has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the “What should I know before using Pomalyst?” ...

As with other drugs, Soliris can cause side effects, such as hair loss. Soliris has a boxed warning. A boxed warning is the most serious warning from the Food and Drug Administration (FDA).

Users viewing an affected release will now see a message in its early access box warning, "The last update made by the developer was over [x] months ago. The information and timeline described ...

As with other drugs, Rapamune can cause side effects. Rapamune has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the ...